Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Cabaletta Bio to Present at Jefferies Virtual Healthcare Conference | ||
By: GlobeNewswire - 27 May 2020 | Back to overview list |
|
PHILADELPHIA, May 27, 2020 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that Steven Nichtberger, M.D., President, Chief Executive Officer and Co-Founder, will participate in a fireside chat at the upcoming Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020, at 3:30 p.m. ET. A live webcast of the presentation will be available on the News and Events section of the company’s website at www.cabalettabio.com. Following the presentation, a replay of the webcast will be available on the website for 90 days. About Cabaletta Bio Contacts: Investors: |
||
|
||
Copyright 2020 GlobeNewswire | Back to overview list |